Pharmafile Logo
Pharmafocus logo
Advanced Search

meningitis

Showing 8 posts of 8 posts found.

vaccination-2722937_960_720

UK govt report looks to reduce vaccination spending

February 27, 2018
Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical

One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …

News
vaccine

Hope in quest for gonorrhoea vaccination

July 11, 2017
Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination

Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …

News
pfizer_finland_hq

EMA to review Pfizer’s meningococcal vaccine

May 20, 2016
Research and Development, Sales and Marketing EMA, Pfizer, meningitis, meningococcal vaccine, trumenba

Pfizer (NYSE: PFE) has announced that the European Medicines Agency has accepting the marketing authorisation application for its meningococcal group …

News
pfizer_hq_new_york

Pfizer completes $130 million purchase of two GSK vaccines

October 5, 2015
Sales and Marketing GSK, Pfizer, meningitis

Pfizer has announced that it has completed the $130 million acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. …

News

Pfizer acquires meningitis vaccines from GSK

June 23, 2015
Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis

Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …

News
Novartis image

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015
Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …

News
novartis image

EU approval for meningitis vaccine

January 23, 2013
Sales and Marketing Bexsero, CHMP, Novartis, meningitis

European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …

News
Ameridose iamge

Meningitis probe extends to NECC sister company

November 1, 2012
Manufacturing and Production NECC, ameridose, meningitis

A second compounding pharmacy has been drawn into the investigation into the meningitis outbreak that has killed 29 people in …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026